Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer

A number of immunotherapies have been developed and adopted for the treatment of urothelial cancer (encompassing cancers arising from the bladder, urethra, or renal pelvis). For these immunotherapies to positively impact patient outcomes, optimal selection of agents and treatment scheduling, especia...

Descripción completa

Detalles Bibliográficos
Autores principales: Galsky, Matthew D, Balar, Arjun V, Black, Peter C, Campbell, Matthew T, Dykstra, Gail S, Grivas, Petros, Gupta, Shilpa, Hoimes, Christoper J, Lopez, Lidia P, Meeks, Joshua J, Plimack, Elizabeth R, Rosenberg, Jonathan E, Shore, Neal, Steinberg, Gary D, Kamat, Ashish M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286774/
https://www.ncbi.nlm.nih.gov/pubmed/34266883
http://dx.doi.org/10.1136/jitc-2021-002552

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286774/
https://www.ncbi.nlm.nih.gov/pubmed/34266883
http://dx.doi.org/10.1136/jitc-2021-002552

Ejemplares similares